Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
1.
Journal of Isfahan Medical School. 2007; 24 (83): 38-43
in Persian | IMEMR | ID: emr-102375

ABSTRACT

The use of narcotics leads to immunodeficiency and infection these patients. Hence, recognition of common germs and appropriate antibiotics is of special importance. This cross-sectional study was performed among all patients hospitalized within 2002-2005, in the ward of infectious diseases, in Alzahra hospital. First, the patients were divided into 4 groups of skin, limb, heart and lung involvement, then microbial culture was obtained and type of bacterium and effective drug. Overall, 493 patients with a mean age of 27.75 years, and a minimum of 15 years. The number of deaths was 59 [11.96], of which, more than half have been affected by infective endocarditis. The most common complication [58.6%] was related to injection site complications. The lung was second [19%] followed by cardiac involvement equivalent to 13.8%. 60% of existing scopes were on tricuspid valve. The most common bacterium, staphylococcus aureus was obtained at a rate of 82.8% from these patients, which responded mostly to cefazolin and gentamicin. The need for vancomycin was present in 2% of patients, which were all hospitalized in the last year of the study [2005], and cefepime was used in only one case. Considering that the most common bacterium was Staphylococcus aureus, with a remarkable majority of patients has given appropriate response to simple and inexpensive drugs cefazolin, gentamicin, ceftriaxone and cloxacillin which are first line of treatment against this bacterium, therefore vancomilyn should be kept for special cases


Subject(s)
Humans , Substance Abuse, Intravenous/microbiology , Cross-Sectional Studies , Drug Users , Bacteria , Immunocompromised Host , Endocarditis , Staphylococcus aureus , Cefazolin , Vancomycin , Ceftriaxone , Gentamicins , Cloxacillin
2.
Rev. chil. cardiol ; 23(2): 104-110, abr.-jun. 2004. tab
Article in Spanish | LILACS | ID: lil-419176

ABSTRACT

La endocarditis infecciosa (EI) persiste como patología frecuente y trascendente. Ha cambiado en relación a la endocarditis subaguda tradicional de antaño: otros tipos de huéspedes, otros factores de riesgo y patologías subyacentes y modificaciones en la distribución etiológica y resistencia de sus agentes causales. Siguen predominando largamente los agentes bacterianos clásicos, aunque se están reconociendo agentes atípicos dados los progresos del diagnóstico microbiológico, serológico y molecular. Desde un punto de vista práctico es útil diferenciar 4 tipos de endocarditis, con distintas manifestaciones, criterios diagnósticos comunes y, en particular, diferente distribución etiológica, que ayuda a buscar con dedicación preferencial los agentes más característicos o, en caso de fallar en el diagnóstico etiológico orientar y dirigir la terapia empírica. Se distingue la clásica EI de paciente valvulópata previo de adquisición extrahospitalaria en donde predomina Streptococcus spp largamente seguido de S aureus y Enterococcus sp. Está luego la EI del paciente con drogadicción endovenosa, excepcional en Chile, cuya etiología mayoritaria es S aureus y en menos grado bacilos Gram negativos (BGN) y menos aún hongos. EI en valvula protésica con etiología variable de acuerdo al momento de ocurrencia, primando S aureus, S coagulasa negativo (SCN), BGN y hongo en la fase precoz, y una distribución más clásica en los casos tardíos sin nunca perder importancia S aureus y SCN. Finalmente están las EI nosocomiales de pacientes con múltiples patologías de base, no siempre cardíacas que hacen EI como consecuencia de bacteremias nosocomiales cuya etiología representa la distribución de éstas, pero predominando S aureus, SCN y BGN.


Subject(s)
Humans , Endocarditis, Bacterial/classification , Endocarditis, Bacterial/etiology , Substance Abuse, Intravenous/microbiology , Gram-Negative Bacteria/pathogenicity , Gram-Positive Bacteria/pathogenicity , Heart Valve Diseases/complications , Cross Infection/microbiology , Heart Valve Prosthesis/microbiology
SELECTION OF CITATIONS
SEARCH DETAIL